Natec Medical has announced that in March, it received a license to market its Tamarin Blue and Filao RX in Canada.
According to a company press release, Tamarin Blue, FDA approved and CE marked, is the “ultimate platform” for all current and future stent and drug-coated technologies. Filao RX (CE marked) is the company’s percutaneous transluminal coronary angioplasty balloon catheter for angioplasty and predilatation
The press release reported that Natec Medical has successfully implemented various levels of services, such as crimping process improvement validation (for stainless steel, bioresorbable and drug -coated stents), bench testing and performance reports, personalised products, sterilisation and regulatory filing.
Natec Medical Ltd will be at EuroPCR (Paris) from the 21st to 24th of May 2013, Booth number P13.
